Arun Kumar Pillai serves as Executive at Outlook Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Arun Kumar Pillai has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 1, 2022 involved transacting 2,500,000 shares valued at $3.1M.
Arun Kumar Pillai currently holds 22,982,529 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arun Kumar Pillai has been a net neutral trader of OTLK stock. They have purchased $0 and sold $0 worth of shares.
Arun Kumar Pillai's most recent insider trade was on Feb 1, 2022, when they sold 2,500,000 shares at $1.25 per share.
Get notified when new Form 4 filings are submitted
| 2,909,091 |
| $0.23 |
| Discretionary |
| Jun 17, 2019 | OTLK | $0 | Option Exercise | 2,181,818 | $N/A | Discretionary |
| Jan 2, 2019 | OTLK | $4.0M | Award | 4,288,624 | $0.93 | Discretionary |